Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone Induction Prior to Glatiramer Acetate in RRMS
NCT00203073Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jun 2003
- Primary completion
- Jan 2005
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of mitoxantrone in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Jun 2003; status: completed.
02
Drugs
mitoxantrone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00203073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203073.